Evidence map›Paper›PMID 33983408›Full record

ArticleGenetics2021

Specific heparan sulfate modifications stabilize the synaptic organizer MADD-4/Punctin at Caenorhabditis elegans neuromuscular junctions.

Mélissa Cizeron, Laure Granger, Hannes E Bülow, Jean-Louis Bessereau

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mélissa CizeronUniv Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217, Institut NeuroMyoGène, Lyon 69008, France.ORCID 0000-0002-2124-1917
Laure GrangerUniv Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217, Institut NeuroMyoGène, Lyon 69008, France.
Hannes E BülowDepartment of Genetics & Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.ORCID 0000-0002-6271-0572
Jean-Louis BessereauUniv Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U 1217, Institut NeuroMyoGène, Lyon 69008, France.ORCID 0000-0002-3088-7621
Université Claude Bernard Lyon 1 · FRAlbert Einstein College of Medicine · US

Funding

Genetic Analyses of Heparan Sulfate Function in Cell-Cell InteractionsR01GM101313 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BUELOW, HANNES ERICH · 2013 to 2016
$1.3M
Novel Approaches to Structure/Function Analyses of Heparan Sulfate in vivoRC1GM090825 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BUELOW, HANNES ERICH · 2009 to 2010
$844k
NIGMS NIH HHS R01 GM101313NIGMS NIH HHS RC1 GM090825
6 · The paper itself

Abstract

Heparan sulfate (HS) proteoglycans contribute to the structural organization of various neurochemical synapses. Depending on the system, their role involves either the core protein or the glycosaminoglycan chains. These linear sugar chains are extensively modified by HS modification enzymes, resulting in highly diverse molecules. Specific modifications of glycosaminoglycan chains may thus contribute to a sugar code involved in synapse specificity. Caenorhabditis elegans is particularly useful to address this question because of the low level of genomic redundancy of these enzymes, as opposed to mammals. Here, we systematically mutated the genes encoding HS modification enzymes in C. elegans and analyzed their impact on excitatory and inhibitory neuromuscular junctions (NMJs). Using single chain antibodies that recognize different HS modification patterns, we show in vivo that these two HS epitopes are carried by the SDN-1 core protein, the unique C. elegans syndecan ortholog, at NMJs. Intriguingly, these antibodies differentially bind to excitatory and inhibitory synapses, implying unique HS modification patterns at different NMJs. Moreover, while most enzymes are individually dispensable for proper organization of NMJs, we show that 3-O-sulfation of SDN-1 is required to maintain wild-type levels of the extracellular matrix protein MADD-4/Punctin, a central synaptic organizer that defines the identity of excitatory and inhibitory synaptic domains at the plasma membrane of muscle cells.

Indexed as

Protein Processing, Post-TranslationalAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsHeparan SulfateNerve Tissue ProteinsNeuromuscular JunctionProtein StabilitySyndecansCaenorhabditis elegans ProteinsHeparan SulfateMADD-4 protein, C elegansNerve Tissue ProteinsSyndecans3-O-sulfotransferaseC. elegansheparan sulfate modification enzymesheparan sulfate proteoglycanMADD-4/Punctinsynapsesynaptomatrixsyndecan

Identifiers

PMID33983408
PMCPMC8864735
OpenAlexW3163905649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.